2025
Apr. New Discovery from the Collaboration Between JelloX and Taipei Medical University:
A comparison was conducted between traditional 2D pathology and JelloX’s 3D pathology on the same colorectal polyp samples. The results revealed that traditional methods misclassified some high-risk lesions as low-risk, while 3D analysis was able to more accurately identify potential malignant transformations.
Apr. In Japan, JelloX is collaborating with the National Cancer Center to conduct clinical studies on colorectal and esophageal cancer patients.
Apr. JelloX Biotech is set to establish a presence at the Discovery Oasis research campus in Phoenix, Arizona. Our new laboratory will integrate AI and 3D imaging technologies, applying these cutting-edge tools to cancer pathology. We have already collaborated with multiple clinical institutions in Taiwan, Japan, and other regions, successfully applying our technology to pathological studies of colorectal cancer, esophageal cancer, and breast cancer (HER2).
2024
Dec. JelloX Aims to Improve Patient-Centered Care with AI-powered 3D Digital Pathology
Dec. Jellox wins another honor, securing the Hsinchu Science Park R&D Achievement Award.
Nov. Awarded the 2024 Neo Star Demo Show Jury Prize
Oct. MetaLite DX Digital Pathology Software obtained FDA 510(k) clearance
Aug. Selected as one of the top ten finalists in the 2024 KPMG Taiwan Tech Innovator competition
May. Invited presentation- Next Generation Intelligent Pathology Driven by 3D Imaging and AI + FL (recommended by Taiwan Society of Personalized Medicine, TSPM)
May. Recommended by Mayo Clinic Chief Digital Innovation Officer in keynote speech of 10th Digital Pathology and AI Conference 2024 (USA)
Apr. Publication in Roche Tucson Symposium- High Biopsy Sampling Rate 3D Pathology for Exploring Biomarker Heterogeneity in Cancer Tissues (USA, recommended by Roche Diagnostics)
Mar. Top 10 Global Startup- Mayo Clinic MedTech Accelerator
Jan. Publication in BMC Cancer- A novel computer-assisted tool for 3D imaging of programmed death-ligand 1 expression in immunofluorescence-stained and optically cleared breast cancer specimens
Jan. Top 8 Biomedical Startup- Taiwan x Berkeley Public Health Program
Jan. The 1st TFDA SaMD Approval- MetaLite DX Digital Pathology Software
2023
Dec. Establishment of digital pathology system in Malaysia medical institutes in collaboration with Intel
Nov. Exhibition in Intel Innovation as an ecosystem innovator of digital pathology with AI on PC
Nov. Publication in ICBBE 2023- Stain-composition augmentation facilitates cross-staining and inter-institutional generalizability of federated learning in computational pathology (Japan)
Oct. Publication in ESMO 2023- Comprehensive diagnosis of PD-L1 from 2D to 3D in breast cancer with AI system (Spain)
Oct. Top 3-Berkeley SkyDeck Accelerator
Sep. TFDA approval- Medical Device Quality Management System
Sep. Publication in Laboratory Investigation- Panoramic tissue examination that integrates 3-dimensional pathology imaging and gene mutation: Potential utility in non-small cell lung cancer
May. Top 10 Award- Healthcare of Select USA Investment Summit (Recommended by Ministry of Economic Affairs)
Apr. Invited presentation- Next Generation Pathology for Precision Healthcare in Intel Vision as an ecosystem innovator (Recommended by Intel)
Jan. Publication in Heliyon- Deep-learning based breast cancer detection for cross-staining histopathology images
2022
Dec. FDA ISO13485:2016 Certificate
Dec. H. Spectrum+ Rising Star Award
Nov. JelloX Biotech CEO Yen-Yin Lin won the third prize of 2022 Best Bio Startup CEO
Oct. Precision diagnosis of nerve invasion in oral cancer with Domain-KEY AI model
Sep. Exhibition in Intel Innovation @ USA as APAC digital health representative
Sep. Oral presentation of precision medicine session in Taiwan-Japan Science and Technology Forum
Sep. Publication in ECP2022-3D biomarker expression and genetic alterations in NSCLC
Sep. Publication in ECP2022-3D diagnosis of HER2 expression-low breast cancers
Aug. Publication in J. Histochemistry & Cytochemistry 2022-Prostate cancer 3D morphology and Gleason scoring
Apr. Publication in J. Translational Medicine-Lung cancer 3D PD-L1 profiling and TPS evaluation
Apr. Recognition as Intel Market Ready Solution
Apr. TW patent issued-I761016
Mar. Get DUNS Registered™ Certificate
Mar. Boehringer Ingelheim’s Grass Roots Initiative Award
Jan. Deep-learning based breast cancer detection for cross-staining histopathology images
Jan. TW patent issued-I753521
Jan. TW patent issued-I753448
2021
Dec. Third Prize-2021 Microsoft The Making of IoT Hackers
Dec. MetaLite 3D digital pathology image analysis software product launch
Nov. The 20th Business Startup Award-MOEA
Nov. Gold Award-Entrepreneur Warrior Competition
Oct. Future Technology Award-MOST
Sep. TW patent issued-I750686
Aug. Set up in Hsinchu Biomedical Science Park
Jul. Recruited by Asia America Multi-Technology Association
Apr.Publication in AACR2021-3D pathology imaging for lung cancer PD-L1 diagnosis
Mar.Publication in FOM2021-3D pathology imaging for breast cancer 3D immunoscoring
Mar.Publication in USCAP2021-3D pathology imaging for prostate cancer morphology diagnosis
Mar. Pre-A run fundraising completed
Feb. Tumor 3D pathology image AI analysis module completed
2020
Nov. Final 8-Beyond BioMed Accelerator Competition
Oct. 3D pathology image cloud computation platform prototype completed
Jul. MetaLite 3D pathology image analysis software prototype completed
Mar. High speed intellent scanner JelloScope prototype completed
Jan. JX ACE 3D pathology image analysis product launch
2019
Dec. Academic Entrepreneur Pioneer Award-MOST
Nov. Final 10-Deep Tech Challenge
Nov. IAPS Award
Oct. Edge computer prototype completed
Jul. Set up at NTHU Innovative Incubation Center
Jun. Angel fundraising completed
2018
Dec. Gold award-MOE Biotech Innovative Startup Competition
Nov. JelloX Biotech Inc. startup with seed fundraising
2017
Jul. Startup team building-MOST valuation creation project